Antibiotic Susceptibility of Conjunctival Bacterial Isolates from Refractive Surgery Patients

Ophthalmology

Volumn 116, Issue 6, 2009, Pages 1067-1074

  Chung, Jae Lim ^a   Seo, Kyoung Yul ^a   Yong, Dong Eun ^a   Mah, Francis S ^b   Kim, Tae im ^a   Kim, Eung Kweon ^a   Kim, Jin Kook ^c  

^a Yonsei University College of Medicine   (South Korea)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c Balgensesang Ophthalmology Clinic   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; AMIKACIN; CEFALOTIN; CEFOTAXIME; CHLORAMPHENICOL; CLARITHROMYCIN; ERYTHROMYCIN; GATIFLOXACIN; GEMIFLOXACIN; IMIPENEM; LEVOFLOXACIN; MOXIFLOXACIN; OFLOXACIN; TOBRAMYCIN; VANCOMYCIN;

ADULT; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL FLORA; BACTERIUM CULTURE; BACTERIUM ISOLATE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CULTURE MEDIUM; FEMALE; FUNGUS CULTURE; GRAM NEGATIVE BACTERIUM; HUMAN; KERATOMILEUSIS; LASER EPITHELIAL KERATOMILEUSIS; LENS IMPLANT; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PHAKIC INTRAOCULAR LENS; PREOPERATIVE PERIOD; PRIORITY JOURNAL; REFRACTIVE SURGERY; SOUTH KOREA; STAPHYLOCOCCUS AUREUS; STREPTOCOCCUS PNEUMONIAE;

ADULT; ANTI-BACTERIAL AGENTS; BACTERIOLOGICAL TECHNIQUES; CONJUNCTIVA; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; KERATECTOMY, SUBEPITHELIAL, LASER-ASSISTED; KERATOMILEUSIS, LASER IN SITU; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; REFRACTIVE SURGICAL PROCEDURES; YOUNG ADULT;

EID: 67349280379     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2008.12.064     Document Type: Article

References (41)

1. Armstrong R.A. The microbiology of the eye. Ophthalmic Physiol Opt 20 (2000) 429-441
2. Chang M.A., Jain S., and Azar D.T. Infections following laser in situ keratomileusis: an integration of the published literature. Surv Ophthalmol 49 (2004) 269-280
3. Karp C.L., Tuli S.S., Yoo S.H., et al. Infectious keratitis after LASIK. Ophthalmology 110 (2003) 503-510
4. Moshirfar M., Welling J.D., Feiz V., et al. Infectious and noninfectious keratitis after laser in situ keratomileusis: occurrence, management, and visual outcomes. J Cataract Refract Surg 33 (2007) 474-483
5. Chong Y., and Lee K. Present situation of antimicrobial resistance in Korea. J Infect Chemother 6 (2000) 189-195
6. Lee K., Lim C.H., Cho J.H., et al., KONSAR Group. High prevalence of ceftazidime-resistant Klebsiella pneumoniae and increase of imipenem-resistant Pseudomonas aeruginosa and Acinetobacter spp. in Korea: a KONSAR program in 2004. Yonsei Med J 47 (2006) 634-645
7. Lee K., Kim M.Y., Kang S.H., et al., Korean Nationwide Surveillance of Antimicrobial Resistance Group. Korean nationwide surveillance of antimicrobial resistance in 2000 with special reference to vancomycin resistance in Enterococci, and expanded-spectrum cephalosporin and imipenem resistance in gram-negative bacilli. Yonsei Med J 44 (2003) 571-578
8. Karlowsky J.A., Kelly L.J., Thornsberry C., et al. Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Int J Antimicrob Agents 19 (2002) 21-31
9. Canton R., Morosini M., Enright M.C., and Morrissey I. Worldwide incidence, molecular epidemiology and mutations implicated in fluoroquinolone-resistant Streptococcus pneumoniae: data from the global PROTEKT surveillance programme. J Antimicrob Chemother 52 (2003) 944-952
10. Lee K., Park K.H., Jeong S.H., et al., KONSAR Group. Further increase of vancomycin-resistant Enterococcus faecium, amikacin- and fluoroquinolone-resistant Klebsiella pneumoniae, and imipenem-resistant Acinetobacter spp. in Korea: 2003 KONSAR surveillance. Yonsei Med J 47 (2006) 43-54
11. McDonald L.C., Lauderdale T.L., Shiau Y.R., et al., TSAR Participating Hospitals. The status of antimicrobial resistance in Taiwan among Gram-positive pathogens: the Taiwan Surveillance of Antimicrobial Resistance (TSAR) programme, 2000. Int J Antimicrob Agents 23 (2004) 362-370
12. Alexandrakis G., Alfonso E.C., and Miller D. Shifting trends in bacterial keratitis in south Florida and emerging resistance to fluoroquinolones. Ophthalmology 107 (2000) 1497-1502
13. Goldstein M.H., Kowalski R.P., and Gordon Y.J. Emerging fluoroquinolone resistance in bacterial keratitis: a 5-year review. Ophthalmology 106 (1999) 1313-1318
14. Hwang D.G. Fluoroquinolone resistance in ophthalmology and the potential role for newer ophthalmic fluoroquinolones. Surv Ophthalmol 49 suppl (2004) S79-S83
15. Chaudhry N.A., Flynn Jr. H.W., Murray T.G., et al. Emerging ciprofloxacin-resistant Pseudomonas aeruginosa. Am J Ophthalmol 128 (1999) 509-510
16. Rhee M.K., Kowalski R.P., Romanowski E.G., et al. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa. Am J Ophthalmol 138 (2004) 226-230
17. Blondeau J.M., Tillotson G., and Deangelis J. Geminofloxacin for the management of community-acquired respiratory tract infections. J Chemother 18 (2006) 582-588
18. Swenson J.M., Tenover F.C., and Cefoxitin Disk Study Group. Results of disk diffusion testing with cefoxitin correlate with presence of mecA in Staphylococcus spp. J Clin Microbiol 43 (2005) 3818-3823
19. Baker C.N., Stocker S.A., Culver D.H., and Thornsberry C. Comparison of the E Test to agar dilution, broth microdilution, and agar diffusion susceptibility testing techniques by using a special challenge set of bacteria. J Clin Microbiol 29 (1991) 533-538
20. Brown D.F., and Brown L. Evaluation of the E test, a novel method of quantifying antimicrobial activity. J Antimicrob Chemother 27 (1991) 185-190
21. Wikler M.A., and National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement (2005), Clinical and Laboratory Standards Institute, Wayne, PA 110-115 CLSI/NCCLS M100-S15
22. Fleiszig S.M., and Efron N. Microbial flora in eyes of current and former contact lens wearers. J Clin Microbiol 30 (1992) 1156-1161
23. McClellan K.A., Cripps A.W., Clancy R.L., and Billson F.A. The effect of successful contact lens wear on mucosal immunity of the eye. Ophthalmology 105 (1998) 1471-1477
24. Miño de Kaspar H., Koss M.J., He L., et al. Antibiotic susceptibility of preoperative normal conjunctival bacteria. Am J Ophthalmol 139 (2005) 730-733
25. Miño de Kaspar H., Shriver E.M., Nguyen E.V., et al. Risk factors for antibiotic-resistant conjunctival bacterial flora in patients undergoing intraocular surgery. Graefes Arch Clin Exp Ophthalmol 241 (2003) 730-733
26. Ta C.N., Chang R.T., Singh K., et al. Antibiotic resistance patterns of ocular bacterial flora: a prospective study of patients undergoing anterior segment surgery. Ophthalmology 110 (2003) 1946-1951
27. Kato T., and Hayasaka S. Methicillin-resistant Staphylococcus aureus and methicillin-resistant coagulase-negative staphylococci from conjunctivas of preoperative patients. Jpn J Ophthalmol 42 (1998) 461-465
28. von Eiff C., Peters G., and Heilmann C. Pathogenesis of infections due to coagulase-negative staphylococci. Lancet Infect Dis 2 (2002) 677-685
29. Watanabe K., Numata-Watanabe K., and Hayasaka S. Methicillin-resistant staphylococci and ofloxacin-resistant bacteria from clinically healthy conjunctivas. Ophthalmic Res 33 (2001) 136-139
30. Hanssen A.M., and Ericson Sollid J.U. SCCmec in staphylococci: genes on the move. FEMS Immunol Med Microbiol 46 (2006) 8-20
31. Mongkolrattanothai K., Boyle S., Murphy T.V., and Daum R.S. Novel non-mecA-containing staphylococcal chromosomal cassette composite island containing pbp4 and tagF genes in a commensal staphylococcal species: a possible reservoir for antibiotic resistance islands in Staphylococcus aureus. Antimicrob Agents Chemother 48 (2004) 1823-1836
32. Naimi T.S., LeDell K.H., Como-Sabetti K., et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 290 (2003) 2976-2984
33. Labandeira-Rey M., Couzon F., Boisset S., et al. Staphylococcus aureus Panton-Valentine leukocidin causes necrotizing pneumonia. Science 315 (2007) 1130-1133
34. David M.Z., Glikman D., Crawford S.E., et al. What is community-associated methicillin-resistant Staphylococcus aureus?. J Infect Dis 197 (2008) 1235-1243
35. Hooper D.C. Fluoroquinolone resistance among Gram-positive cocci. Lancet Infect Dis 2 (2002) 530-538
36. Venezia R.A., Domaracki B.E., Evans A.M., et al. Selection of high-level oxacillin resistance in heteroresistant Staphylococcus aureus by fluoroquinolone exposure. J Antimicrob Chemother 48 (2001) 375-381
37. Dalhoff A., and Schmitz F.J. In vitro antibacterial activity and pharmacodynamics of new quinolones. Eur J Clin Microbiol Infect Dis 22 (2003) 203-221
38. File Jr. T.M., Schlemmer B., Garau J., et al., 049 Clinical Study Group. Efficacy and safety of gemifloxacin in the treatment of community-acquired pneumonia: a randomized, double-blind comparison with trovafloxacin. J Antimicrob Chemother 48 (2001) 67-74
39. Vousden M., Ferguson J., Richards J., et al. Evaluation of phototoxic potential of gemifloxacin in healthy volunteers compared with ciprofloxacin. Chemotherapy 45 (1999) 512-520
40. Donnenfeld E.D., Kim T., Holland E.J., et al. ASCRS White Paper: Management of infectious keratitis following laser in situ keratomileusis. J Cataract Refract Surg 31 (2005) 2008-2011
41. Hamam R.N., Noureddin B., Salti H.I., et al. Recalcitrant post-LASIK Mycobacterium chelonae keratitis eradicated after the use of fourth-generation fluoroquinolone. Ophthalmology 113 (2006) 950-954